Skip to main content

The Influence of Cisternal and Ventricular Lavage on Cerebral Vasospasm in Patients Suffering from Subarachnoid Hemorrhage: Analysis of Effectiveness

  • Conference paper
Early Brain Injury or Cerebral Vasospasm

Part of the book series: Acta Neurochirurgica Supplements ((NEUROCHIRURGICA,volume 110/2))

Abstract

Objective: Within the last decades several clinical trials were performed to analyze the effectiveness of cisternal and ventricular lavage on cerebral vasospasm in patients suffering from subarachnoid hemorrhage. Aim of the present analysis was to review and summarize all documented clinical studies using cisternal or ventricular lavage to prevent vasospasm.

Methods: The MEDLINE Web site (www.pub.med.com) was searched using the clinical query function optimized for clinical therapy. Search terms were subarachnoid hemorrhage, vasospasm, cisternal and ventricular lavage. Results were divided into cisternal and ventricular lavage therapies alone and its combination with additional treatment modalities.

Results: So far the literature search revealed a total of nine clinical trials using cisternal or ventricular lavage alone in patients suffering from subarachnoid hemorrhage. The patients were treated using urokinase or recombinant tissue plasminogen activator. A metaanalysis, investigating a total of 652 included patients revealed a significant reduction of delayed neurological deficits, a significant increase of outcome and a significant decrease of mortality in the treatment group. Additional there was no difference of effectiveness or side effects using urokinase or recombinant tissue plasminogen activator. Hence, only one of these studies was based on a prospective, randomized study design. A combination of cisternal or ventricular lavage with some sort of kinetic treatment was documented in a total of three studies. All of them were designed prospectively. The combined application demonstrated reduced delayed neurological deficits, reduced vasospasm and better outcome in two studies for the treatment group. One study was stopped early due to unexpected complication.

Conclusions: In conclusion, there is strong evidence that cisternal or ventricular lavage alone and in combination with kinetic therapy lead to a reduction of cerebral vasospasm and better outcome in patients suffering from subarachnoid hemorrhage. As a consequence a prospective randomized study would be of great interest.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Amin-Hanjani S, Ogilvy CS, Barker FG, II. Does intracisternal thrombolysis prevent vasospasm after aneurysmal subarachnoid hemorrhage? A meta-analysis. Neurosurgery 2004;54:326–34; discussion 334–325.

    Article  PubMed  Google Scholar 

  2. Aoki N. “Head-shaking syndrome” neurological deterioration during continuous head-shaking as an adjunct to cisternal irrigation for clot removal in patients with acute subarachnoid haemorrhage. Acta Neurochir (Wien). 1995;132:20–25.

    Article  CAS  Google Scholar 

  3. Barker FG, II, Ogilvy CS. Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis. J Neurosurg. 1996;84:405–414.

    Article  PubMed  Google Scholar 

  4. Barth M, Capelle HH, Weidauer S, Weiss C, Munch E, Thome C, et al. Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind phase IIa study. Stroke 2007;38:330–336.

    Article  PubMed  CAS  Google Scholar 

  5. Findlay JM. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm. Neurosurgery 1995;37:1026–1027.

    Article  PubMed  CAS  Google Scholar 

  6. Gorski R, Zabek M, Jarmuzek P. Influence of intraoperative using of recombinant tissue plasminogen activator on the development of cerebral angiospasm after subarachnoid haemorrhage in patients with ruptured intracranial aneurysms. Neurol Neurochir Pol. 2000;34:41–47.

    PubMed  CAS  Google Scholar 

  7. Haley EC, Jr, Kassell NF, Alves WM, Weir BK, Hansen CA. Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg. 1995;82:786–790.

    Article  PubMed  Google Scholar 

  8. Haley EC, Jr, Kassell NF, Apperson-Hansen C, Maile MH, Alves WM. A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America. J Neurosurg. 1997;86:467–474.

    Article  PubMed  CAS  Google Scholar 

  9. Hanggi D, Eicker S, Beseoglu K, Behr J, Turowski B, Steiger HJ. A multimodal concept in patients after severe aneurysmal subarachnoid hemorrhage: results of a controlled single centre prospective randomized multimodal phase I/II trial on cerebral vasospasm. Cen Eur Neurosurg. 2009;70:61–67.

    Article  CAS  Google Scholar 

  10. Hanggi D, Liersch J, Turowski B, Yong M, Steiger HJ. The effect of lumboventricular lavage and simultaneous low-frequency head-motion therapy after severe subarachnoid hemorrhage: results of a single center prospective Phase II trial. J Neurosurg. 2008;108:1192–1199.

    Article  PubMed  Google Scholar 

  11. Hänggi D, Liersch J, Wöbker G, Steiger H. Simultaneous head rotation and lumboventricular lavage in patients after severe subarachnoid haemorrhage: An initial analysis of the influence on clot clearance rate and cerebral vasospasm. Acta Neurochir Suppl. 2008;104:315–319.

    Article  Google Scholar 

  12. Hop JW, Rinkel GJ, Algra A, van Gijn J. Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke 1997;28:660–664.

    Article  PubMed  CAS  Google Scholar 

  13. Kanamura K, Waga S, Sakakura M, Morikawa A, Yamamoto Y, Marooka Y, et al. Comparative study of cisternal lavage methods for the treatment of cerebral vasospasm. In: Findlay JM, editor. Cerebral vasospasm: proceedings of the Vth international conference on cerebral vasospasm. Amsterdam: Elsevier Science Publishers; 1993. p. 471–473.

    Google Scholar 

  14. Kassell NF, Torner JC, Haley EC, Jr, Jane JA, Adams HP, Kongable GL. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results. J Neurosurg. 1990;73:18–36.

    Article  PubMed  CAS  Google Scholar 

  15. Kasuya H, Onda H, Sasahara A, Takeshita M, Hori T. Application of nicardipine prolonged-release implants: analysis of 97 consecutive patients with acute subarachnoid hemorrhage. Neurosurgery 2005;56:895–902; discussion 895–902.

    PubMed  Google Scholar 

  16. Kawamoto S, Tsutsumi K, Yoshikawa G, Shinozaki MH, Yako K, Nagata K, et al. Effectiveness of the head-shaking method combined with cisternal irrigation with urokinase in preventing cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg. 2004;100:236–243.

    Article  PubMed  Google Scholar 

  17. Lanzino G, Kassell NF. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America. J Neurosurg. 1999;90:1018–1024.

    Article  PubMed  CAS  Google Scholar 

  18. Lanzino G, Kassell NF, Dorsch NW, Pasqualin A, Brandt L, Schmiedek P, et al. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa. J Neurosurg. 1999;90:1011–1017.

    Article  PubMed  CAS  Google Scholar 

  19. Majchrzak H, Lech A, Kopera M, Gajos L, Dragan T, Ladzinski P. [Application of alteplase in prevention of cerebral vasospasm and its sequelae in patients after aneurysmal subarachnoid hemorrhage from ruptured cerebral aneurysm]. Neurol Neurochir Pol. 1995;29:379–387.

    PubMed  CAS  Google Scholar 

  20. Mizoi K, Yoshimoto T, Takahashi A, Fujiwara S, Koshu K, Sugawara T. Prospective study on the prevention of cerebral vasospasm by intrathecal fibrinolytic therapy with tissue-type plasminogen activator. J Neurosurg. 1993;78:430–437.

    Article  PubMed  CAS  Google Scholar 

  21. Moriyama E, Matsumoto Y, Meguro T, Kawada S, Mandai S, Gohda Y, et al. Combined cisternal drainage and intrathecal urokinase injection therapy for prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage. Neurol Med Chir (Tokyo). 1995;35:732–736.

    Article  CAS  Google Scholar 

  22. Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, van Gijn J. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2005:CD000277.

    Google Scholar 

  23. Rinkel GJ, Feigin VL, Algra A, van Gijn J. Circulatory volume expansion therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2004:CD000483.

    Google Scholar 

  24. Saito I, Segawa H, Mishima K, Sano K. Prevention of postoperative vasospasm by cisternal irrigation with and without urokinase. In: Sano K, Takakura K, Kassell NF, Sasaki T, editors. Cerebral vasospasm: proceedings of the IVth international conference on cerebral vasospasm. Tokyo: Elsevier Science Publishers; 1990. p. 297–301.

    Google Scholar 

  25. Seifert V, Stolke D, Zimmermann M, Feldges A. Prevention of delayed ischaemic deficits after aneurysmal subarachnoid haemorrhage by intrathecal bolus injection of tissue plasminogen activator (rTPA). A prospective study. Acta Neurochir (Wien). 1994;128:137–143.

    Article  CAS  Google Scholar 

  26. Suarez JI, Tarr RW, Selman WR. Aneurysmal subarachnoid hemorrhage. N Engl J Med. 2006;354:387–396.

    Article  PubMed  CAS  Google Scholar 

  27. Suzuki IS, Takahashi H. Effect of head-shaking method on clot removal in cisternal irrigation. Cerebral vasospasm.Tokya: University of Tokyo Press;1990. p. 314–316.

    Google Scholar 

  28. Treggiari-Venzi MM, Suter PM, Romand JA. Review of medical prevention of vasospasm after aneurysmal subarachnoid hemorrhage: a problem of neurointensive care. Neurosurgery 2001;48:249–61; discussion 261–242.

    PubMed  CAS  Google Scholar 

  29. Treggiari MM, Walder B, Suter PM, Romand JA. Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage. J Neurosurg. 2003;98:978–984.

    Article  PubMed  Google Scholar 

  30. Usui M, Saito N, Hoya K, Todo T. Vasospasm prevention with postoperative intrathecal thrombolytic therapy: a retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone. Neurosurgery 1994;34:235–44; discussion 244–235.

    Article  PubMed  CAS  Google Scholar 

  31. Weyer GW, Nolan CP, Macdonald RL. Evidence-based cerebral vasospasm management. Neurosurg Focus. 2006;21:E8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniel Hänggi .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag/Wien

About this paper

Cite this paper

Hänggi, D., Steiger, HJ. (2011). The Influence of Cisternal and Ventricular Lavage on Cerebral Vasospasm in Patients Suffering from Subarachnoid Hemorrhage: Analysis of Effectiveness. In: Feng, H., Mao, Y., Zhang, J.H. (eds) Early Brain Injury or Cerebral Vasospasm. Acta Neurochirurgica Supplements, vol 110/2. Springer, Vienna. https://doi.org/10.1007/978-3-7091-0356-2_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-0356-2_17

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-0355-5

  • Online ISBN: 978-3-7091-0356-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics